Vikas Sinha

Insider Reports History

Entity
Individual
Location
C/O Alexion Pharmacueticals, Inc., 352 Knotter Drive, Cheshire, CT
Signature
/s/ Brett Hagen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vikas Sinha:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allovir, Inc. Officer Title: President and Chief Financial Officer, Director, 10%+ Owner Common Stock 16.7M $9.15M $0.55 Nov 19, 2024 Shares held by ElevateBio LLC
Allovir, Inc. Officer Title: President and Chief Financial Officer, Director, 10%+ Owner Common Stock 1.14M $626K $0.55 Nov 19, 2024 Direct
Verona Pharma plc Director Share Options (Right to Buy) 240K Apr 29, 2024 Direct

Insider Reports Filed by Vikas Sinha

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALVR Allovir, Inc. Nov 19, 2024 1 -$1.75K 4 Nov 20, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Nov 5, 2024 1 -$4.44K 4 Nov 6, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Oct 21, 2024 2 -$2.65K 4 Oct 23, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Oct 3, 2024 1 -$766 4 Oct 4, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Aug 19, 2024 1 -$2.4K 4 Aug 20, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Aug 5, 2024 1 -$3.86K 4 Aug 7, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Jul 19, 2024 2 -$2.53K 4 Jul 23, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Jul 2, 2024 1 -$676 4 Jul 3, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. May 17, 2024 1 -$2.36K 4 May 21, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. May 3, 2024 1 -$3.95K 4 May 7, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
VRNA Verona Pharma plc Apr 29, 2024 1 $0 4 Apr 30, 2024 Director
ALVR Allovir, Inc. Apr 19, 2024 2 -$2.53K 4 Apr 23, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Apr 2, 2024 1 -$683 4 Apr 4, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Feb 20, 2024 1 -$2.01K 4 Feb 22, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Feb 5, 2024 1 -$12.3K 4 Feb 6, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Jan 23, 2024 1 -$2.15K 4 Jan 25, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Jan 4, 2024 1 -$614 4 Jan 8, 2024 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Nov 17, 2023 1 -$4.06K 4 Nov 21, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Oct 19, 2023 2 -$4.22K 4 Oct 23, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Oct 3, 2023 1 -$1.49K 4 Oct 5, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Aug 17, 2023 1 -$26.2K 4 Aug 21, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Jul 19, 2023 2 -$9.08K 4 Jul 21, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Jul 5, 2023 1 -$9.08K 4 Jul 6, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
VRNA Verona Pharma plc Apr 28, 2023 1 $0 4 Apr 28, 2023 Director
ALVR Allovir, Inc. Apr 19, 2023 2 -$9.83K 4 Apr 21, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Feb 2, 2023 2 $0 4 Feb 3, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Jan 19, 2023 2 -$33.3K 4 Jan 23, 2023 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Oct 20, 2022 1 -$13.6K 4/A Oct 26, 2022 Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Oct 19, 2022 1 -$13.6K 4 Oct 24, 2022 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Aug 16, 2022 1 $0 4 Aug 17, 2022 Officer Title: President and Chief Financial Officer, Director
ALVR Allovir, Inc. Jul 28, 2022 1 $15M 4 Aug 1, 2022 Officer Title: President and Chief Financial Officer, Director, 10%+ Owner
ALVR Allovir, Inc. Jul 20, 2022 1 -$7.47K 4 Jul 21, 2022 Officer Title: President and Chief Financial Officer, Director
ALVR Allovir, Inc. Jul 1, 2022 2 $0 4 Jul 6, 2022 Officer Title: President and Chief Financial Officer, Director
VRNA Verona Pharma plc Apr 28, 2022 1 $0 4 Apr 29, 2022 Director
ALVR Allovir, Inc. Apr 20, 2022 1 -$7.77K 4 Apr 22, 2022 Officer Title: President and Chief Financial Officer, Director
ALVR Allovir, Inc. Jan 20, 2022 1 -$56.5K 4 Jan 24, 2022 Officer Title: President & Chief Financial Officer, Director
ALVR Allovir, Inc. Jan 18, 2022 2 $0 4 Apr 4, 2022 Officer Title: President and Chief Financial OFficer, Director
VRNA Verona Pharma plc Aug 9, 2021 1 $0 4 Aug 10, 2021 Director